| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/16/2015 |
3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 465 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | 05/20/2012(1) | 05/20/2016 | Common Stock | 3,334 | $1.45 | D | |
| Stock Option (Right to Buy) | 10/14/2012(2) | 10/14/2016 | Common Stock | 3,334 | $1.1 | D | |
| Stock Option (Right to Buy) | 04/12/2012(3) | 04/12/2017 | Common Stock | 6,250 | $1.69 | D | |
| Stock Option (Right to Buy) | 04/16/2014(4) | 04/16/2018 | Common Stock | 7,500 | $3.76 | D | |
| Stock Option (Right to Buy) | 03/05/2015(5) | 03/05/2019 | Common Stock | 15,000 | $3.45 | D | |
| Explanation of Responses: |
| 1. On May 20, 2011 Jennifer Balliet was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. Jennifer exercised 6,666 of these options and she currently has 3,334 options available to exercise. |
| 2. On October 14, 2011 Jennifer Balliet was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Jennifer Balliet exercised 6,666 options from this grant and has 3,334 options available to be exercised. |
| 3. On April 12, 2012 Jennifer Balliet was granted 12,500 stock options. One quarter of these options vested immediately and the remaining options vested on the next three anniversary dates of the grant date. Jennifer Balliet has exercised 6,250 stock options from this grant and has 6,250 stock options available to be exercised. |
| 4. On April 16, 2013 Jennifer Balliet was granted 7,500 stock options. The options vest ratably over the first three anniversary dates of the grant date. |
| 5. On March 5, 2014 Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. |
| /s/ Jennifer Balliet | 04/24/2015 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||